Author:
Honoré N.,van Marcke C.,Galot R.,Helaers R.,Ambroise J.,van Maanen A.,Mendola A.,Dahou H.,Marbaix E.,Van Eeckhout P.,Longton E.,Magremanne M.,Schmitz S.,Limaye N.,Machiels J.-P.
Reference38 articles.
1. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Machiels;Ann Oncol,2020
2. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial;Lee;Lancet Oncol,2021
3. Afatinib vs placebo as adjuvant therapy after chemoradiotherapy in squamous cell carcinoma of the head and neck: a randomized clinical trial;Burtness;JAMA Oncol,2019
4. Primary results of the phase III KEYNOTE-412 study: pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC);Machiels;Ann Oncol,2022
5. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer;Tie;JAMA Oncol,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献